1.
Product Overview
1.1.
Market Definition
1.2.
Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for Study
1.2.3.
Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7. Assumptions
and Limitations
3.
Executive Summary
3.1.
Overview of the Market
3.2.
Overview of Key Market Segmentations
3.3.
Overview of Key Market Players
3.4.
Overview of Key Regions/Countries
3.5.
Overview of Market Drivers, Challenges, and Trends
4.
Voice of Customer
5. Global
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook
5.1.
Market Size & Forecast
5.1.1.
By Value
5.2.
Market Share & Forecast
5.2.1.
By Service Type (In House, Contract Outsourcing)
5.2.2.
By Synthesis Type (Chemical-based API, Biological API,
HPAPI)
5.2.3.
By Animal Type (Production Animals, Companion Animals)
5.2.4.
By Therapeutic Category (Antiparasitic,
Anti-infectives, NSAIDs, Others)
5.2.5.
By Company (2023)
5.2.6.
By Region
5.3.
Market Map
6. North
America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1. By
Service Type
6.2.2. By
Synthesis Type
6.2.3. By
Animal Type
6.2.4.
By Therapeutic Category
6.2.5.
By Country
6.3.
North America: Country Analysis
6.3.1.
United States Veterinary Active Pharmaceutical
Ingredients Manufacturing Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Service Type
6.3.1.2.2.
By Synthesis Type
6.3.1.2.3.
By Animal Type
6.3.1.2.4.
By Therapeutic Category
6.3.2.
Mexico Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Service Type
6.3.2.2.2.
By Synthesis Type
6.3.2.2.3.
By Animal Type
6.3.2.2.4.
By Therapeutic Category
6.3.3.
Canada Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Service Type
6.3.3.2.2.
By Synthesis Type
6.3.3.2.3.
By Animal Type
6.3.3.2.4.
By Therapeutic Category
7. Europe
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By
Service Type
7.2.2.
By Synthesis Type
7.2.3.
By Animal Type
7.2.4.
By Therapeutic Category
7.2.5.
By Country
7.3.
Europe: Country Analysis
7.3.1.
France Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Service Type
7.3.1.2.2.
By Synthesis Type
7.3.1.2.3.
By Animal Type
7.3.1.2.4.
By Therapeutic Category
7.3.2.
Germany Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Service Type
7.3.2.2.2.
By Synthesis Type
7.3.2.2.3.
By Animal Type
7.3.2.2.4.
By Therapeutic Category
7.3.3.
United Kingdom Veterinary Active Pharmaceutical
Ingredients Manufacturing Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Service Type
7.3.3.2.2.
By Synthesis Type
7.3.3.2.3.
By Animal Type
7.3.3.2.4.
By Therapeutic Category
7.3.4.
Italy Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Service Type
7.3.4.2.2.
By Synthesis Type
7.3.4.2.3.
By Animal Type
7.3.4.2.4.
By Therapeutic Category
7.3.5.
Spain Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Service Type
7.3.5.2.2.
By Synthesis Type
7.3.5.2.3.
By Animal Type
7.3.5.2.4.
By Therapeutic Category
8. Asia-Pacific
Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1. By
Service Type
8.2.2.
By Synthesis Type
8.2.3.
By Animal Type
8.2.4.
By Therapeutic Category
8.2.5.
By Country
8.3.
Asia-Pacific: Country Analysis
8.3.1.
China Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Service Type
8.3.1.2.2.
By Synthesis Type
8.3.1.2.3.
By Animal Type
8.3.1.2.4.
By Therapeutic Category
8.3.2.
India Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Service Type
8.3.2.2.2.
By Synthesis Type
8.3.2.2.3.
By Animal Type
8.3.2.2.4.
By Therapeutic Category
8.3.3.
South Korea Veterinary Active Pharmaceutical
Ingredients Manufacturing Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Service Type
8.3.3.2.2.
By Synthesis Type
8.3.3.2.3.
By Animal Type
8.3.3.2.4.
By Therapeutic Category
8.3.4.
Japan Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Service Type
8.3.4.2.2.
By Synthesis Type
8.3.4.2.3.
By Animal Type
8.3.4.2.4.
By Therapeutic Category
8.3.5.
Australia Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Service Type
8.3.5.2.2.
By Synthesis Type
8.3.5.2.3.
By Animal Type
8.3.5.2.4.
By Therapeutic Category
9. South
America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1. By
Service Type
9.2.2.
By Synthesis Type
9.2.3.
By Animal Type
9.2.4.
By Therapeutic Category
9.2.5.
By Country
9.3.
South America: Country Analysis
9.3.1.
Brazil Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Service Type
9.3.1.2.2.
By Synthesis Type
9.3.1.2.3.
By Animal Type
9.3.1.2.4.
By Therapeutic Category
9.3.2.
Argentina Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Service Type
9.3.2.2.2.
By Synthesis Type
9.3.2.2.3.
By Animal Type
9.3.2.2.4.
By Therapeutic Category
9.3.3.
Colombia Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Service Type
9.3.3.2.2.
By Synthesis Type
9.3.3.2.3.
By Animal Type
9.3.3.2.4.
By Therapeutic Category
10. Middle
East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1. By
Service Type
10.2.2.
By Synthesis Type
10.2.3.
By Animal Type
10.2.4.
By Therapeutic Category
10.2.5.
By Country
10.3.
MEA: Country Analysis
10.3.1.
South Africa Veterinary Active Pharmaceutical
Ingredients Manufacturing Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Service Type
10.3.1.2.2.
By Synthesis Type
10.3.1.2.3.
By Animal Type
10.3.1.2.4.
By Therapeutic Category
10.3.2.
Saudi Arabia Veterinary Active Pharmaceutical
Ingredients Manufacturing Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Service Type
10.3.2.2.2.
By Synthesis Type
10.3.2.2.3.
By Animal Type
10.3.2.2.4.
By Therapeutic Category
10.3.3.
UAE Veterinary Active Pharmaceutical Ingredients
Manufacturing Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Service Type
10.3.3.2.2.
By Synthesis Type
10.3.3.2.3.
By Animal Type
10.3.3.2.4.
By Therapeutic Category
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends & Developments
12.1.
Merger & Acquisition (If Any)
12.2.
Product Launches (If Any)
12.3.
Recent Developments
13.
Porters Five Forces Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Products
14.
Competitive Landscape
14.1.
Zoetis Inc.
14.1.1. Business
Overview
14.1.2. Company
Snapshot
14.1.3. Products
& Services
14.1.4. Financials
(As Reported)
14.1.5. Recent
Developments
14.1.6. Key
Personnel Details
14.1.7. SWOT
Analysis
14.2.
Alivira Animal Health Limited
14.3.
Ofichem Group
14.4.
Chempro Group
14.5.
Siflon Group
14.6.
Qilu Animal Health Products Co., Ltd.
14.7.
Chemo Holding, S.L
14.8.
SUAN FARMA S.A.U
14.9.
MENADIONA
14.10.
Excel Industries Ltd
15.
Strategic Recommendations
16.
About Us & Disclaimer